Artículos por temáticas

Cysteamine as a novel disease-modifying compound for Parkinson's disease: Over a decade of research supporting a clinical trial.

Cicchetti F, David LS, Siddu A, Denis HL.

Neurobiol Dis. 2019 Oct;130:104530. doi: 10.1016/j.nbd.2019.104530. Epub 2019 Jul 10. Review.

Higher zinc concentrations in hair of Parkinson's disease are associated with psychotic complications and depression.

Dos Santos AB, Bezerra MA, Rocha ME, Barreto GE, Kohlmeier KA.

J Neural Transm (Vienna). 2019 Oct;126(10):1291-1301. doi: 10.1007/s00702-019-02041-9. Epub 2019 Jul 11.

Destroyed non-dopaminergic pathways in the early stage of Parkinson's disease assessed by posturography.

Halmi Z, Dinya E, Málly J.

Brain Res Bull. 2019 Oct;152:45-51. doi: 10.1016/j.brainresbull.2019.07.001. Epub 2019 Jul 8.

Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease Drosophila PINK1B9 model.

Baroli B, Loi E, Solari P, Kasture A, Moi L, Muroni P, Kasture S, Setzu MD, Liscia A, Zavattari P.

FASEB J. 2019 Oct 1;33(10):11028-11034. doi: 10.1096/fj.201901010. Epub 2019 Jul 10.

Dopaminergic modulation of motor network compensatory mechanisms in Parkinson's disease.

Jastrzębowska MA, Marquis R, Melie-García L, Lutti A, Kherif F, Herzog MH, Draganski B.

Hum Brain Mapp. 2019 Oct 15;40(15):4397-4416. doi: 10.1002/hbm.24710. Epub 2019 Jul 10.

The challenge of pain in the pharmacological management of Parkinson's disease.

Jost WH, Buhmann C.

Expert Opin Pharmacother. 2019 Oct;20(15):1847-1854. doi: 10.1080/14656566.2019.1639672. Epub 2019 Jul 10.

Kir6.1/K-ATP channel on astrocytes protects against dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease via promoting mitophagy.

Hu ZL, Sun T, Lu M, Ding JH, Du RH, Hu G.

Brain Behav Immun. 2019 Oct;81:509-522. doi: 10.1016/j.bbi.2019.07.009. Epub 2019 Jul 6.

Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease.

Yakufujiang M, Higuchi Y, Aoyagi K, Yamamoto T, Abe M, Okahara Y, Izumi M, Nagano O, Yamanaka Y, Hirano S, Shiina A, Murata A, Iwadate Y.

Acta Neurochir (Wien). 2019 Oct;161(10):2049-2058. doi: 10.1007/s00701-019-03991-5. Epub 2019 Jul 5.

Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.

Barbosa RP, Mendonça MD, Caetano AP, Lampreia TM, Miguel R, Bugalho PM.

J Neural Transm (Vienna). 2019 Oct;126(10):1329-1335. doi: 10.1007/s00702-019-02042-8. Epub 2019 Jul 5.

Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.

Shehadeh J, Double KL, Murphy KE, Bobrovskaya L, Reyes S, Dunkley PR, Halliday GM, Dickson PW.

Neurobiol Dis. 2019 Oct;130:104524. doi: 10.1016/j.nbd.2019.104524. Epub 2019 Jul 2.

Deep brain stimulation for Parkinson's disease modulates high-frequency evoked and spontaneous neural activity.

Sinclair NC, McDermott HJ, Fallon JB, Perera T, Brown P, Bulluss KJ, Thevathasan W.

Neurobiol Dis. 2019 Oct;130:104522. doi: 10.1016/j.nbd.2019.104522. Epub 2019 Jul 2.

Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.

Kouli A, Horne CB, Williams-Gray CH.

Brain Behav Immun. 2019 Oct;81:41-51. doi: 10.1016/j.bbi.2019.06.042. Epub 2019 Jul 2. Review.

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson's Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway.

Zhang Y, Xu W, Nan S, Chang M, Fan J.

J Mol Neurosci. 2019 Oct;69(2):197-214. doi: 10.1007/s12031-019-01349-1. Epub 2019 Jul 3.

The PRIAMO study: active sexual life is associated with better motor and non-motor outcomes in men with early Parkinson's disease.

Picillo M, Palladino R, Erro R, Colosimo C, Marconi R, Antonini A, Barone P; PRIAMO study group..

Eur J Neurol. 2019 Oct;26(10):1327-1333. doi: 10.1111/ene.13983. Epub 2019 Jul 2.

Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.

Sarkar A, Rawat N, Sachan N, Singh MP.

Neurotox Res. 2019 Oct;36(3):627-644. doi: 10.1007/s12640-019-00080-4. Epub 2019 Jul 2. Review.